ТИРОНЕТ – все о щитовидной железе Для специалистов Журнал Тиронет Архив журнала 2000 год № 5-6

Влияние лекарственных препаратов на функцию щитовидной железы

Джан Р. Стокигт (Jan R Stockigt)
Thyroid international - 2-2000 редакторы: Г. Хеннеманн и Е.П. Креннинг (Роттердам)издатель: компания Мерк КGaA, Дармштадт, Германия
Русский перевод к.м.н. Фадеева В.В.(примечания переводчика отмечены *)


  1. Ain KB, Refetoff S. Relationship of oligosaccharide modification to the cause of serum thyroxine binding globulin excess. J Clin Endocrinol Metab 1988;66:1037-1043.
  2. Arafah BM. Decreased levothyroxine requirement in women with hypothyroidism during androgen therapy for breast cancer. Ann Intern Med 1994; 121:247-251.
  3. Baudin E, Marcellin P, Pouteau M et al. Reversibility of thyroid dysfunction induced by recombinant alpha interferon in chronic hepatitis C. Clin Endocrinol 1993;39:657-661.
  4. Bishnoi A, Carlson He, Gruber Bl et al. Effects of commonly prescribed nonsteroidal anti-inflammotory agents on thyroid hormone measurements. Am J Med 1994; 96: 235-238.
  5. Blackshear JI, Schultz AL, Napier JS, Stuart DD. Thyroxine replacement requirements in hypothyroid patients receiving phenytoin. Ann Intern Med 1983; 99:341-342.
  6. Blumberg B, Sabbagh W, Juguilon H et al. SRX, a novel steroid and xenobiotic sensing nuclear receptor. Genes and Development 1998;12:3195-3205.
  7. Bogazzi F, Bartalena L, Brogioni S et al. Color flow Doppler sonography rapidly differentiates Type I and Type II amiodarone-induced thyrotoxicosis. Thyroid 1997;7:541-545.
  8. Brabant A, Brabant G, Schuermeyer T et al. The role of glucocorticoids in the regulation of thyrotropin. Acta Endocrinol 1989; 121;95-100.
  9. Chetkowski RJ, Meldrum DR, Steingold KA et al. Biologic effects of transdermal estradiol. N Eng J Med 1986;314:1615-1620.
  10. Coles AJ, Wing M, Smith S et al. Pulsed monoclonal antibody treatment and autoimmune thyroid disease in multiple sclerosis. Lancet 1999; 354:1691-95.
  11. Cooper DS. Antithyroid drugs. N Engl J Med 1984; 311: 1353-1362.
  12. Cooper et al. Hyperthyroxinemia in patients treated with high-dose propranolol. Am J Med 1982; 73; 867-871.
  13. Corssmit EPM, Heyligenberg R, Endert E et al. Acute effects of interferon-a administration on thyroid hormone metabolism in healthy men. J Clin Endocrinol Metab 1995; 80:3140-3144.
  14. Curran PG, DeGroot LJ. The effect of hepatic enzyme-inducing drugs on thyroid hormones and the thyroid gland. Endocr Rev 1991; 12:135-150.
  15. DiVito M, Biegel L, Brouwer A et al. Screening methods for thyroid hormone disruptors. Environ Health Persp 1999; 107:407-415.
  16. Felicetta JV, Green WL, Nelp WB. Inhibition of hepatic binding of thyroxine by cholecystographic agents. J Clin Invest 1980; 65: 1032-1040.
  17. Gupta A, Eggo MC, Uetrecht JP et al. Drug-induced hypothyroidism: the thyroid as a target organ in hypersensitivity reactions to anticonvulsants and sulphonamides. Clin Pharm Ther 1992; 51:56-67.
  18. Harjai KJ, Licata AA. Effects of amiodarone on thyroid function. Ann Intern Med 1997;126:63-73.
  19. Hawkins RC. Furosemide interference in newer free thyroxine assays. Clin Chem 1998; 44:2550-2551.
  20. Jaume JC, Mendel CM, Frost PH et al. Extremely low doses of heparin release lipase activity into the plasma and can thereby cause artefactual elevations in the serum free thyroxine concentrations as measured by equilibrium dialysis. Thyroid 1996; 6: 79-83.
  21. Koh LKH, Greenspan FS, Yeo PPB. Interferon-a induced thyroid dysfunction: three clinical presentations and a review of the literature. Thyroid 1997;6:891-896.
  22. Lazarus JH Effects of lithium on the thyroid gland. In: Weetman AP, Grossman A eds. Pharmacotherapeutics of the thyroid gland. Berlin, Springer, 1996; pp 207-223.
  23. Lee E, Chen P, Rao H et al. Effect of acute high dose dobutamine on serum thyrotrophin. Clin Endocrinol 1999;50:487-492.
  24. Leuprasitsakul W, Alex S, Fang SL et al. Flavonoid administration immediately displaces T4 from serum transthyretin, increases serum free T4 and decreases serum thyrotropin in the rat. Endocrinology 1990; 126: 2890-2895.
  25. Lim C-F, Bai Y, Topliss DJ et al. Drug and fatty acid effects on serum thyroid hormone binding. J Clin Endocrinol Metab 1988; 67: 682-688.
  26. Lim C-F, Stockigt JR, Curtis AJ et al. Influence of a naturally-occurring furanoid acid on the potency of drug competitors for specific thyroxine binding in serum. Metabolism 1993; 42:1468-1474.
  27. McCowen KC, Garber JR, Spark R. Elevated serum thyrotropin in thyroxine-treated patients with hypothyroidism given sertraline. N Engl J Med 1997; 337;1010-1011.
  28. Mendel CM, Frost PH, Cavalieri RR. Effect of free fatty acids on the concentration of free thyroxine in human serum; the role of albumin. J Clin Endocrinol Metab 1986; 63: 1394-1399.
  29. Mendel CM, Frost PH, Kunitake ST, Cavalieri RR. Mechanism of the heparin-induced increase in the concentration of free thyroxine in plasma. J Clin Endocrinol Metab 1987;65:1259-1264.
  30. Morley JE, Shafer RB, Elson MK et al. Amphetamine-induced hyperthyroxinemia. Ann Intern Med 1980; 93:707-709.
  31. Newnham HH, Hamblin PS, Long F et al. Effect of oral frusemide on diagnostic indices of thyroid function. Clin Endocrinol 1987; 26:423-431.
  32. Reinhardt W, Sauter V, Jockenhцvel F et al. Unique alterations of thyroid function parameters after iv administration of alkylating drugs cyclophosphamide and ifosfamide. Exp Clin Endocrinol Diab 1999; 107;177-182.
  33. Roti E, Braverman LE. Iodine-induced thyroid disease. In: Contemporary Endocrinology, Diseases of the Thyroid, ed Braverman LE, Humana Press, Totowa, New Jersey, 1997, pp 369-383.
  34. Sapin R, Schlienger J-L, Gasser F et al. Intermethod discordant free thyroxine measurements in bone marrow-transplanted patients. Clin Chem 2000; 46; 418-422.
  35. Sherman SI, Tielens ET, Ladenson PW. Sucralfate causes malabsorption of l-thyroxine. Am J Med 1994; 96: 531-535.
  36. Smith PJ, Surks MI. Multiple effects of diphenylhydantoin on the thyroid hormone system. Endocr Rev 1984; 5:514-524.
  37. Smyrk TC, Goellner JR, Brennan MD, Carney JA. Pathology of the thyroid in amiodarone-associated thyrotoxicosis. Am J Surg Path 1987; 11:197-204.
  38. Stevenson HP, Archbold GPR, Johnston P et al. Misleading serum free thyroxine results during low molecular weight heparin treatment. Clin Chem 1998;44:1002-1007.
  39. Stockigt JR, Lim C-F, Barlow JW et al. High concentrations of furosemide inhibit plasma binding of thyroxine. J Clin Endocrinol Metab 1984; 59: 62-66.
  40. Stockigt JR, Lim C-F, Barlow JW, Topliss DJ. Thyroid hormone transport In: Weetman AP, Grossman A eds. Pharmacotherapeutics of the thyroid gland. Berlin:Springer 1996:119-150.
  41. Surks MI, Defesi CR. Normal free thyroxine concentrations in patients treated with phenytoin or carbamazepine: a paradox resolved. JAMA 1996; 275:1495-1498.
  42. Surks MI, Sievert R. Drugs and thyroid function. N Engl J Med 1995;333:1688-1694.
  43. Van den Berghe G, de Zegher F, Lauwers P. Dopamine and the sick euthyroid syndrome in critical illness. Clin Endocrinol 1994;41:731-737.
  44. Wang R, Nelson JC, Wilcox RB. Salsalate administration - a potential pharmacological model of the sick euthyroid syndrome. J Clin Endocrinol Metab 1998;83:3095-3099.
  45. Wenzel KW. Pharmacological interference with in vitro tests of thyroid function. Metabolism 1981; 30:717-732.
  46. Wiersinga WM. Amiodarone and the thyroid. In: Weetman AP, Grossman A eds. Pharmacotherapeutics of the thyroid gland. Berlin:Springer 1996:225-287.